nash

medical student

FDA approves novel treatment to target abnormality in sickle cell disease, what is sickle cell disease

215 Hits nash Nov 11, 2021, 5:20 PM

The U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older.